Sesquiterpene Lactone Parthenolide Ameliorates Bladder Inflammation and Bladder Overactivity in Cyclophosphamide Induced Rat Cystitis Model by Inhibiting Nuclear Factor-κB Phosphorylation

Journal of Urology

Volumn 181, Issue 5, 2009, Pages 2339-2348

  Kiuchi, Hiroshi ^a   Takao, Tetsuya ^a   Yamamoto, Keisuke ^a   Nakayama, Jiro ^a   Miyagawa, Yasushi ^a   Tsujimura, Akira ^a   Nonomura, Norio ^a   Okuyama, Akihiko ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

cyclophosphamide; cystitis; NF kappa B; parthenolide; urinary bladder

Indexed keywords

CYCLOOXYGENASE 2; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PARTHENOLIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYSTITIS; ENZYME ACTIVATION; HEMORRHAGIC CYSTITIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INHIBITION KINETICS; NONHUMAN; OVERACTIVE BLADDER; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; RAT; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; BIOPSY, NEEDLE; CYCLOPHOSPHAMIDE; CYSTITIS; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; NF-KAPPA B; PHOSPHORYLATION; PROBABILITY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SENSITIVITY AND SPECIFICITY; SESQUITERPENES; URINARY BLADDER, OVERACTIVE;

EID: 64049091647     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.01.015     Document Type: Article

References (20)

1. Levine A.L., and Richie P.J. Urological complications of cyclophosphamide. J Urol 141 (1989) 1063
2. Stillwell T.J., and Benson R.C. Cyclophosphamide-induced hemorrhagic cystitis: a review of 100 patients. Cancer 61 (1988) 451
3. Etlik O., Tomur A., Deveci S., Pişkin I., and Pekcan M. Comparison of the uroprotective efficacy of mesna and HBO treatments in cyclophosphamide-induced hemorrhagic cystitis. J Urol 158 (1997) 2296
4. Ribeiro R.A., Freitas H.C., Campos M.C., Santos C.C., Figueiredo F.C., Brito G.A., et al. Tumor necrosis factor-α and interleukin-1β mediate the production of nitric oxide involved in the pathogenesis of ifosphamide induced hemorrhagic cystitis in mice. J Urol 167 (2002) 2229
5. Hu V.Y., Malley S., Dattilio A., Folsom J.B., Zvara P., and Vizzard M.A. COX-2 and prostanoid expression in micturition pathways after cyclophosphamide-induced cystitis in the rat. Am J Physiol 284 (2003) R574
6. Baeuerle P.A., and Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 12 (1994) 141
7. Saadane A., Masters S., DiDonato J., Li J., and Berger M. Parthenolide inhibits IkappaB kinase, NF-kappaB activation, and inflammatory response in cystic fibrosis cells and mice. Am J Respir Cell Mol Biol 36 (2007) 728
8. Tak P.P., and Firestein G.S. NF-κB: a key role in inflammatory diseases. J Clin Invest 107 (2001) 7
9. Yang W.L., Roland I.H., Godwin A.K., and Xu X.X. Loss of TNF-alpha-regulated COX-2 expression in ovarian cancer cells. Oncogene 24 (2005) 7991
10. Heinrich M. Ethnopharmacology of Mexican Asteraceae (Compositae). Annu Rev Pharmacol Toxicol 38 (1998) 539
11. Francescato H.D., Costa R.S., Scavone C., and Coimbra T.M. Parthenolide reduces cisplatin-induced renal damage. Toxicology 230 (2007) 64
12. Oka D., Nishimura K., Shiba M., Nakai Y., Arai Y., Nakayama M., et al. Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF-kappaB. Int J Cancer 120 (2007) 2576
13. Velasco C., Angelico P., Guarneri L., Leonardi A., Clarke D.E., and Testa R. Effects of the nuclear factor-kappaB inhibitors 2-hydroxy-4-trifluoromethylbenzoic acid and aspirin on micturition in rats with normal and inflamed bladder. J Urol 166 (2001) 1962
14. Abdel-Mageed A.B., and Ghoniem G.M. Potential role of rel/nuclear factor-kappaB in the pathogenesis of interstitial cystitis. J Urol 160 (1998) 2000
15. Wang X.C., Saban R., Kaysen J.H., Saban M.R., Allen P.L., Benes E.N., et al. Nuclear factor kappa B mediates lipopolysaccharide-induced inflammation in the urinary bladder. J Urol 163 (2000) 993
16. Alfieri A.B., Malave A., and Cubeddu L.X. Nitric oxide synthases and cyclophosphamide-induced cystitis in rats. Naunyn Schmiede Arch Pharmacol 363 (2001) 353
17. Sasaki C.Y., Barberi T.J., Ghosh P., and Longo D.L. Phosphorylation of RelA/p65 on serine 536 defines an I{kappa}B{alpha}-independent NF-{kappa}B pathway. J Biol Chem 280 (2005) 34538
18. Vieira M.M., Brito G.A., Belarmino-Filho J.N., Macedo F.Y., Nery E.A., Cunha F.Q., et al. Use of dexamethasone with mesna for the prevention of ifosfamide-induced hemorrhagic cystitis. Int J Urol 10 (2003) 595
19. Sweeney C.J., Mehrotra S., Sadaria M.R., Kumar S., Shortle N.H., Roman Y., et al. The sesquiterpene lactone parthenolide in combination with docetaxel reduces metastasis and improves survival in a xenograft model of breast cancer. Mol Cancer Ther 4 (2005) 1004
20. Hewamana S., Alghazal S., Lin T.T., Clement M., Jenkins C., Guzman M.L., et al. The NF-kappaB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target. Blood 111 (2008) 468